跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,143 条关于
“MTX-439”
全部
3,143
临床试验
1,974
药物
841
机构
36
资讯
292
8个月前
Mediar Therapeutics Secures $76 Million Series B to Advance First-in-Class Anti-Fibrotic Pipeline
上个月
Mediar Therapeutics Enters Collaboration with Ono Pharma to Develop Novel Antibody Therapeutics for Fibro-inflammatory Diseases
2年前
Mediar Therapeutics Advances Fibrosis Treatment with Phase 1 Trial of MTX-463
去年
Merakris Therapeutics' MTX-001 Selected as Finalist for Advanced Wound Care Innovation Showcase
9个月前
Merakris Therapeutics Achieves FDA Alignment on MTX-001 Development Pathway for Chronic Venous Leg Ulcers
11个月前
Merakris Therapeutics Secures FDA Type C Meeting to Advance MTX-001 Wound Healing Therapy
4个月前
MEKanistic Therapeutics Receives FDA Clearance for First-in-Class Dual PI3K/EGFR Inhibitor MTX-531
5个月前
Merakris Therapeutics Reports Positive Interim Data for MTX-001 in Venous Leg Ulcers, Advances Toward Late-Stage Development
4年前
Half-Dose Glucarpidase Effective in Reducing Toxic Methotrexate Levels
去年
Lilly and Mediar Therapeutics Partner to Advance Novel IPF Therapy
第 1 页,共 30 页
上一页
下一页